↓ Skip to main content

A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia
Published in
Orphanet Journal of Rare Diseases, February 2022
DOI 10.1186/s13023-022-02230-y
Pubmed ID
Authors

Yohei Sugiyama, Taijiro Watanabe, Makiko Tajika, Tetsuro Matsuhashi, Masaru Shimura, Takuya Fushimi, Keiko Ichimoto, Ayako Matsunaga, Tomohiro Ebihara, Tomoko Tsuruoka, Tomoyuki Akiyama, Kei Murayama

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 11%
Student > Bachelor 3 8%
Student > Ph. D. Student 2 6%
Student > Master 2 6%
Professor 2 6%
Other 4 11%
Unknown 19 53%
Readers by discipline Count As %
Medicine and Dentistry 6 17%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 2 6%
Social Sciences 2 6%
Business, Management and Accounting 1 3%
Other 5 14%
Unknown 18 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2022.
All research outputs
#13,628,211
of 23,500,709 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,397
of 2,702 outputs
Outputs of similar age
#186,683
of 443,118 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#49
of 140 outputs
Altmetric has tracked 23,500,709 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,702 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,118 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.